跳至主要内容
临床试验/DRKS00004305
DRKS00004305招募中不适用

Retro- and prospective observational study evaluating MSI and KRAS for prognosis of early colorectal cancer stage I, II and III - ColoPredict Plus 2.0 Register

Institut für Pathologie der Ruhr-Universität Bochum0 个研究点开始时间: 2013年1月9日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patients, treated at participating sites are eligible for participation if they fulfill all oft he following criteria:
  • prospective enrollment:
  • Male or female patient with CC UICC stage I, II or III
  • Cooperating pathology willing to provide tissue samples for research according to study protocol
  • Age = 18 years and able to understand the concept of the registry and give informed consent
  • signed informed consent for registry participation according to ICH-GCP guidelines
  • retrospective enrollment:
  • primary diagnosis since 1st January 2006
  • other inclusion criteria according to protocoll version 5.1.1

排除标准

  • patients that
  • do not fulfill inclusion criteria
  • withdraw consent to participate

研究者

发起方
Institut für Pathologie der Ruhr-Universität Bochum

相似试验

Retro- and prospective observational study... | 临床试验